Role of EUS in colon lesions Pietro Fusaroli Gastroenterologia Università di Bologna.

Slides:



Advertisements
Similar presentations
Neoadjuvant therapy for Rectal cancer
Advertisements

Diagnosis.
IN THE NAME OF GOD. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy The American Journal.
Taunton SpR Training Day 7th December 2012 Early rectal cancer
Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
Management of Malignant Polyps Santhat Nivatvongs, MD Colon and Rectal Surgery Mayo Clinic Rochester Minnesota U.S.A.
Endoscopic Ultrasound in Rectal Cancer Natasha Schneider November 15, 2010.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
Amy Schindler 10/18/10.  Endoscopic appearance: Early cancers: superficial plaque, nodule, or ulceration Advanced lesions: strictures, ulcerated masses,
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Management of large rectal adenoma Dr. Hester YS Cheung Department of surgery Pamela Youde Nethersole Eastern Hospital.
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
Joint Hospital Surgical Grand Round KL FOK NDH/AHNH Department of Surgery.
ANDREW NG PRINCE OF WALES HOSPITAL Role of primary chemoradiation in esophageal carcinoma.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
CRM (T stage) Low rectal cancer Nodal disease Risk Factors for Loc recurrence.
Malignant colonic polyp: endoscopic treatment updates
Practice Guidelines and Consensus on Capsule Endoscopy
Slawomir Marecik, MD, FACS, FASCRS Advocate Lutheran General Hospital, Park Ridge, IL Clinical Assistant Professor University of Illinois, Chicago, USA.
Defining the Colorectal Surgeons role in patients with colorectal cancer and limited metastatic disease Jose G. Guillem, MD, MPH Department of Surgery.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Treatment of Early Malignant Rectal Polyp
A REVISIT TO MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOUR (GIST) Joint Hospital Surgical Grand Round 17 Jan 2015 Grace Liu Pamela Youde Nethersole Eastern.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Dept Surgery, Colorectal unit University Hospital, Uppsala, Sweden
Capecitabine versus 5-fluorouracil-based (neo-)adjuvant chemo-radiotherapy for locally advanced rectal cancer: Long term results.
SURGERY FOR NSCLC GREG CHRISTODOULIDES MD, FACS, FCCP, FESTS
What are the usual sites of recurrence What are the usual sites of recurrence LocalLocal distantdistant Benefits Benefits Palliative chemo ± radiationPalliative.
Imaging Metastatic Rectal Cancer Jack Temple, MS3 June 2013 Christian Malalis, MD.
A. MONTORI M.D. F.A.C.S. PROFESSOR OF SURGERY UNIVERSITY OF ROME “LA SAPIENZA” President of EAcSS HOW TO AVOID MAJOR SURGERY IN RECTAL CANCER MSO-MTCC.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
Radiotherapy for Colo-rectal Cancer. Case 1 בן 58 גידול בגובה 9 ס"ם מפי הטבעת קולונוסקופיה – גידול צירקולרי, כמעט חוסם TRUS T3 N0 מועמד לניתוח TME טיפול??
What is the Preferable Treatment Option for T1/T2 Low Rectal Cancer? Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology.
Potentially curative re-resection of recurrent CRC  Suture line recurrences  Isolated liver metastases  Isolated pulmonary metastases.
1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim,
Recent Advances in Head and Neck Cancer Robert I. Haddad, M.D., and Dong M. Shin, M.D. The NEW ENGLAND JOURNAL of MEDICINE N Engl J Med 2008;359:
Gastric Cancer Gidon Almogy MD Department of General Surgery Hadassah University Hospital.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
RT with TME surgery ? OUTLINEOUTLINE. Prostate Seminal vessels Neurovascular bundle Denonvilliers Fascia “holy plane” (Fascia rectalis) Total Mesorectal.
Accuracy of EUS in diagnosis of rectal cancer KKUH experience
LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,
Synchronous Metastasis on Staging/Surveillance CT chest abdomen & Pelvis + CEA + MRI Liver /PET-CT Synchronous Metastasis on Staging/Surveillance CT chest.
Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
Duel Acquisition Neck CTA/ CT for Pre-TLM H&N Ca Patient Evaluation Steven M. Weindling, M.D. Mayo Clinic Florida XIX Symposium.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Role of MRI in Primary Rectal Cancer Staging and Management
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer V. Heinemann*, M. Haas & S. Boeck Annals of Oncology 24: 2484–2492,
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society.
Simposio: “Pancreatic Cancer: Surgical Treatment, 2013” Roma, 26 marzo 2013.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
종양혈액내과 R4 고원진 / pf. 김시영 Rectal cancer : state of the art in 2012 Curr Opin Oncol 2012, 24:441–447.
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Laparoscopic surgery for rectal cancer What is the evidence?
Karcinom rektuma- management
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
Dr Jessica Jenkins Consultant Oncologist
Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion- weighted MR imaging in the response assessment after neoadjuvant.
Oesophageal and Gastric cancer: neo-adjuvant therapy
Capecitabine versus 5-fluorouracil-based (neo-)adjuvant chemoradiotherapy for locally advanced rectal cancer: safety results of a randomized phase III.
Neoadjuvant Adjuvant Curative Palliative
Do all patients with T2-3 mid-high rectal adenocarcinomas require RT as part of their neoadjuvant therapy? - Yes - 
 Bruce Minsky.
Presentation transcript:

Role of EUS in colon lesions Pietro Fusaroli Gastroenterologia Università di Bologna

EUS in colon polypoid lesions Evaluation before endoscopic treatment –Only in selected cases Evaluation during resection –Cumbersome, no proven advantage Evaluation of radicality of resection –Does not add to histology Post polypectomy surveillance –No role, does not add to histology

EUS accuracy in T1 stage lesions Puli et al. Dig Dis Sci 2009

EUS: T1a

EUS: T1b

Follow up

Prediction of bleeding The absence of vessels on EUS did not rule out the possibility of bleeding Polkowski et al. Endoscopy 2003

Miniprobe or dedicated? Miniprobe Pros –Quick –Image small lesions –Real time resection –Stenotic tumors Cons –Limited penetration –Expensive Dedicated echoendoscope Pros –Image stability –Good penetration –Power Doppler Cons –Separate examination –Stenotic tumors –Small lesions

EUS in rectal cancer Accurate staging of rectal cancer facilitates selection of pts. who will benefit from preoperative multi-modality tx Pts. with rectal cancer who warrant adjuvant tx are those with advanced locoregional disease [tumor extension into the perirectal and/or involvement of the mesorectal or pelvic lymph nodes (T3, T4 N0, or any T N1,2)] Neoadjuvant tx followed by surgery results in better local control and reduced toxicity when compared with standard post-op adjuvant regimens

Rectal lesions: treatment options EMR/ESD Transanal local excision Transanal microsurgery (TEM) Total mesorectal excision Chemo/radiotherapy

EUS accuracy in T staging Puli et al. Ann Surg Oncol 2009

EUS vs. CT vs. MR: meta-analysis Bipat et al. Radiology 2004

EUS: T2 The case for surgery

EUS: T3 The case for neoadjuvant Rx

EUS: T4 The case for palliative Rx

EUS FOR RECTAL CANCER: CONS Disappointing results in a large multi-center study finding agreement between pre- and post-operative staging in only 63.3% of cases (lowest agreement for T3 stage!) Hospitals and endosonographers with very different experiences, in terms of volume of cases per year and years of activity, were involved Centralization of EUS appears essential to ensure a high quality level of this technique Marusch et al. Endoscopy 2002

EUS: LEARNING CURVE # casesSite/lesion 25EUS-guided FNA (pancreatic) 25EUS-guided FNA (nonpancreatic) 75Pancreaticobiliary 40Submucosal tumors 75Mucosal tumors (cancer staging) Eisen et al. Gastrointest Endosc 2001

RESTAGING POST CHEMORADIO Pts. re-referral for EUS after neoadjuvant tx is increasing EUS before and after 5-fluorouracil and hyperfractionated radiotherapy in 82 pts. with rectal cancer Overall T staging was correct in only 48% of the pts. (vs. 81% without chemoradio). Understaging occurred in 14% of the cases, and overstaging occurred in 38% Inability to differentiate between residual tumor and radiation-induced inflammation and fibrosis Vanagunas et al. Am J Gastroenterol 2004

EUS FOR POST-OP FOLLOW UP Most local rectal cancer recurrences occur extraluminally Among 116 pts., accuracy for detection of recurrence was only 79% with EUS but rose to 100% with EUS-FNA Early detection led to potential curative reintervention in 31 pts., of whom 25 were detected by EUS alone Lohnert et al. Dis Colon Rectum 2000

EUS-FNA: RECURRENCE

EUS-FNA: NO RECURRENCE

thank you for your attention